MOTS stock forecast
Our latest prediction for Motus GI Holdings, Inc.'s stock price was made on the Nov. 20, 2019 when the stock price was at 1.51$.
In the short term (2weeks), MOTS's stock price should outperform the market by 6.88%. During that period the price should oscillate between -8.09% and +17.96%.
In the medium term (3months), MOTS's stock price should outperform the market by 8.83%. During that period the price should oscillate between -20.77% and +51.54%.
Get email alertsCreate a solid portfolio with MOTS
About Motus GI Holdings, Inc.
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in September, 2016 and is headquartered in Fort Lauderdale, FL.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.06$ per share.
The book value per share is 0.86$
Three months stock forecastNov. 20, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -950.00% | -23M | - | -23M | -1.06 | - | - | 22M | 0.86 | -19M | -1M | -20M |